Hnatko-Kołacz M, Armata J, Dłuzniewska A
Kliniki Hematologii Dzieciecej Polsko-Amerykańskiego Instytutu Pediatrii Collegium Medicum U. J. W Krakowie.
Pol Merkur Lekarski. 1997 Feb;2(8):113-5.
The results of treatment in 45 children with rhabdomyosarcoma was presented. Two-years survival was achieved in 63% and five-year in 45%. The importance of location and group of clinical progression discussed was importance prognostic factors in rhabdomyosarcoma.
